nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Dinoprostone—SLC51A—osteoporosis	0.0156	0.842	CrCbGaD
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—CNR2—osteoporosis	0.015	0.0973	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.0148	0.0958	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—CNR2—osteoporosis	0.0147	0.0952	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.0144	0.0938	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—MGLL—osteoporosis	0.00373	0.0242	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—MGLL—osteoporosis	0.00365	0.0237	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00334	0.0217	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00327	0.0212	CbGpPWpGaD
Carboprost Tromethamine—Dinoprostone—CYP19A1—osteoporosis	0.00293	0.158	CrCbGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTH1R—osteoporosis	0.00237	0.0154	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CALCR—osteoporosis	0.00237	0.0154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CALCR—osteoporosis	0.00232	0.0151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTH1R—osteoporosis	0.00232	0.0151	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00186	0.0121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00182	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00159	0.0103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00156	0.0101	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Ibandronate—osteoporosis	0.00146	0.00176	CcSEcCtD
Carboprost Tromethamine—Nausea—Ergocalciferol—osteoporosis	0.00145	0.00175	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00143	0.00173	CcSEcCtD
Carboprost Tromethamine—Angioedema—Ethinyl Estradiol—osteoporosis	0.00143	0.00172	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Estradiol—osteoporosis	0.00142	0.00172	CcSEcCtD
Carboprost Tromethamine—Tension—Pamidronate—osteoporosis	0.00142	0.00172	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Estropipate—osteoporosis	0.00141	0.00171	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00141	0.0017	CcSEcCtD
Carboprost Tromethamine—Flushing—Zoledronate—osteoporosis	0.00141	0.0017	CcSEcCtD
Carboprost Tromethamine—Nervousness—Pamidronate—osteoporosis	0.00141	0.0017	CcSEcCtD
Carboprost Tromethamine—Back pain—Pamidronate—osteoporosis	0.0014	0.00169	CcSEcCtD
Carboprost Tromethamine—Somnolence—Estropipate—osteoporosis	0.0014	0.00169	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Pamidronate—osteoporosis	0.00139	0.00168	CcSEcCtD
Carboprost Tromethamine—Angioedema—Risedronate—osteoporosis	0.00139	0.00168	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00139	0.00168	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00137	0.00166	CcSEcCtD
Carboprost Tromethamine—Vertigo—Risedronate—osteoporosis	0.00137	0.00165	CcSEcCtD
Carboprost Tromethamine—Syncope—Risedronate—osteoporosis	0.00137	0.00165	CcSEcCtD
Carboprost Tromethamine—Chills—Zoledronate—osteoporosis	0.00136	0.00165	CcSEcCtD
Carboprost Tromethamine—Cough—Ethinyl Estradiol—osteoporosis	0.00136	0.00165	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Estradiol—osteoporosis	0.00136	0.00164	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Ibandronate—osteoporosis	0.00135	0.00164	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00134	0.00162	CcSEcCtD
Carboprost Tromethamine—Pain—Estropipate—osteoporosis	0.00134	0.00162	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTH1R—osteoporosis	0.00134	0.00869	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CALCR—osteoporosis	0.00134	0.00869	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Etidronic acid—osteoporosis	0.00134	0.00162	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Risedronate—osteoporosis	0.00134	0.00162	CcSEcCtD
Carboprost Tromethamine—Cough—Risedronate—osteoporosis	0.00133	0.00161	CcSEcCtD
Carboprost Tromethamine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00132	0.0016	CcSEcCtD
Carboprost Tromethamine—Pain—Alendronate—osteoporosis	0.00132	0.0016	CcSEcCtD
Carboprost Tromethamine—Angioedema—Pamidronate—osteoporosis	0.00132	0.0016	CcSEcCtD
Carboprost Tromethamine—Hypertension—Risedronate—osteoporosis	0.00131	0.00159	CcSEcCtD
Carboprost Tromethamine—Somnolence—Calcitriol—osteoporosis	0.00131	0.00159	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTH1R—osteoporosis	0.00131	0.00851	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CALCR—osteoporosis	0.00131	0.00851	CbGpPWpGaD
Carboprost Tromethamine—Pain—Raloxifene—osteoporosis	0.0013	0.00157	CcSEcCtD
Carboprost Tromethamine—Syncope—Pamidronate—osteoporosis	0.0013	0.00157	CcSEcCtD
Carboprost Tromethamine—Chest pain—Risedronate—osteoporosis	0.0013	0.00157	CcSEcCtD
Carboprost Tromethamine—Myalgia—Risedronate—osteoporosis	0.0013	0.00157	CcSEcCtD
Carboprost Tromethamine—Anxiety—Risedronate—osteoporosis	0.00129	0.00156	CcSEcCtD
Carboprost Tromethamine—Pain—Ibandronate—osteoporosis	0.00129	0.00156	CcSEcCtD
Carboprost Tromethamine—Back pain—Zoledronate—osteoporosis	0.00128	0.00155	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Pamidronate—osteoporosis	0.00127	0.00154	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Zoledronate—osteoporosis	0.00127	0.00154	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Estradiol—osteoporosis	0.00127	0.00153	CcSEcCtD
Carboprost Tromethamine—Infection—Ethinyl Estradiol—osteoporosis	0.00127	0.00153	CcSEcCtD
Carboprost Tromethamine—Cough—Pamidronate—osteoporosis	0.00126	0.00153	CcSEcCtD
Carboprost Tromethamine—Pain—Calcitriol—osteoporosis	0.00126	0.00152	CcSEcCtD
Carboprost Tromethamine—Hypertension—Pamidronate—osteoporosis	0.00125	0.00151	CcSEcCtD
Carboprost Tromethamine—Tension—Conjugated Estrogens—osteoporosis	0.00125	0.00151	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Zoledronate—osteoporosis	0.00125	0.00151	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTH—osteoporosis	0.00124	0.00808	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Etidronic acid—osteoporosis	0.00124	0.0015	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Estropipate—osteoporosis	0.00124	0.0015	CcSEcCtD
Carboprost Tromethamine—Nervousness—Conjugated Estrogens—osteoporosis	0.00124	0.00149	CcSEcCtD
Carboprost Tromethamine—Infection—Risedronate—osteoporosis	0.00123	0.00149	CcSEcCtD
Carboprost Tromethamine—Myalgia—Pamidronate—osteoporosis	0.00123	0.00149	CcSEcCtD
Carboprost Tromethamine—Back pain—Conjugated Estrogens—osteoporosis	0.00123	0.00149	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Estradiol—osteoporosis	0.00123	0.00149	CcSEcCtD
Carboprost Tromethamine—Anxiety—Pamidronate—osteoporosis	0.00123	0.00148	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Alendronate—osteoporosis	0.00122	0.00148	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00122	0.00148	CcSEcCtD
Carboprost Tromethamine—Shock—Risedronate—osteoporosis	0.00122	0.00148	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTH—osteoporosis	0.00122	0.00791	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTH1R—osteoporosis	0.00122	0.00789	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CALCR—osteoporosis	0.00122	0.00789	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CNR2—osteoporosis	0.00121	0.00788	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Zoledronate—osteoporosis	0.00121	0.00146	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Raloxifene—osteoporosis	0.0012	0.00145	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Conjugated Estrogens—osteoporosis	0.0012	0.00145	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Ibandronate—osteoporosis	0.00119	0.00144	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CALCR—osteoporosis	0.00119	0.00773	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTH1R—osteoporosis	0.00119	0.00773	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Zoledronate—osteoporosis	0.00119	0.00144	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CNR2—osteoporosis	0.00119	0.00771	CbGpPWpGaD
Carboprost Tromethamine—Syncope—Zoledronate—osteoporosis	0.00119	0.00143	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Pamidronate—osteoporosis	0.00118	0.00143	CcSEcCtD
Carboprost Tromethamine—Infection—Pamidronate—osteoporosis	0.00117	0.00142	CcSEcCtD
Carboprost Tromethamine—Palpitations—Zoledronate—osteoporosis	0.00117	0.00141	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Calcitriol—osteoporosis	0.00117	0.00141	CcSEcCtD
Carboprost Tromethamine—Angioedema—Conjugated Estrogens—osteoporosis	0.00116	0.00141	CcSEcCtD
Carboprost Tromethamine—Shock—Pamidronate—osteoporosis	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Zoledronate—osteoporosis	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Estropipate—osteoporosis	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Vomiting—Etidronic acid—osteoporosis	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Cough—Zoledronate—osteoporosis	0.00115	0.00139	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Pamidronate—osteoporosis	0.00115	0.00139	CcSEcCtD
Carboprost Tromethamine—Rash—Etidronic acid—osteoporosis	0.00115	0.00138	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Etidronic acid—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Vertigo—Conjugated Estrogens—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Pamidronate—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Syncope—Conjugated Estrogens—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Hypertension—Zoledronate—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Alendronate—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—WNT1—osteoporosis	0.00114	0.0074	CbGpPWpGaD
Carboprost Tromethamine—Headache—Etidronic acid—osteoporosis	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00113	0.00137	CcSEcCtD
Carboprost Tromethamine—Asthenia—Estropipate—osteoporosis	0.00113	0.00136	CcSEcCtD
Carboprost Tromethamine—Myalgia—Zoledronate—osteoporosis	0.00113	0.00136	CcSEcCtD
Carboprost Tromethamine—Chest pain—Zoledronate—osteoporosis	0.00113	0.00136	CcSEcCtD
Carboprost Tromethamine—Palpitations—Conjugated Estrogens—osteoporosis	0.00112	0.00136	CcSEcCtD
Carboprost Tromethamine—Anxiety—Zoledronate—osteoporosis	0.00112	0.00136	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00112	0.00135	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—WNT1—osteoporosis	0.00112	0.00725	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Risedronate—osteoporosis	0.00112	0.00135	CcSEcCtD
Carboprost Tromethamine—Asthenia—Alendronate—osteoporosis	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Ibandronate—osteoporosis	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Cough—Conjugated Estrogens—osteoporosis	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Risedronate—osteoporosis	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Estradiol—osteoporosis	0.00109	0.00132	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Calcitriol—osteoporosis	0.00109	0.00131	CcSEcCtD
Carboprost Tromethamine—Flushing—Estradiol—osteoporosis	0.00109	0.00131	CcSEcCtD
Carboprost Tromethamine—Chest pain—Conjugated Estrogens—osteoporosis	0.00108	0.00131	CcSEcCtD
Carboprost Tromethamine—Myalgia—Conjugated Estrogens—osteoporosis	0.00108	0.00131	CcSEcCtD
Carboprost Tromethamine—Asthenia—Ibandronate—osteoporosis	0.00108	0.00131	CcSEcCtD
Carboprost Tromethamine—Anxiety—Conjugated Estrogens—osteoporosis	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Nausea—Etidronic acid—osteoporosis	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Zoledronate—osteoporosis	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Estropipate—osteoporosis	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Infection—Zoledronate—osteoporosis	0.00107	0.0013	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—MGLL—osteoporosis	0.00106	0.00691	CbGpPWpGaD
Carboprost Tromethamine—Pain—Risedronate—osteoporosis	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Shock—Zoledronate—osteoporosis	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Pamidronate—osteoporosis	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Alendronate—osteoporosis	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Asthenia—Calcitriol—osteoporosis	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Pamidronate—osteoporosis	0.00105	0.00127	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Zoledronate—osteoporosis	0.00105	0.00127	CcSEcCtD
Carboprost Tromethamine—Chills—Estradiol—osteoporosis	0.00105	0.00127	CcSEcCtD
Carboprost Tromethamine—Somnolence—Pamidronate—osteoporosis	0.00105	0.00127	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Zoledronate—osteoporosis	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Raloxifene—osteoporosis	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—MGLL—osteoporosis	0.00104	0.00676	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Estropipate—osteoporosis	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—Infection—Conjugated Estrogens—osteoporosis	0.00103	0.00125	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Ibandronate—osteoporosis	0.00103	0.00125	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTHLH—osteoporosis	0.00103	0.0067	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Alendronate—osteoporosis	0.00102	0.00124	CcSEcCtD
Carboprost Tromethamine—Shock—Conjugated Estrogens—osteoporosis	0.00102	0.00123	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00101	0.00123	CcSEcCtD
Carboprost Tromethamine—Pain—Pamidronate—osteoporosis	0.00101	0.00122	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Calcitriol—osteoporosis	0.00101	0.00122	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTHLH—osteoporosis	0.00101	0.00655	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00101	0.00122	CcSEcCtD
Carboprost Tromethamine—Dizziness—Raloxifene—osteoporosis	0.00101	0.00122	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.001	0.00121	CcSEcCtD
Carboprost Tromethamine—Tension—Estradiol—osteoporosis	0.001	0.00121	CcSEcCtD
Carboprost Tromethamine—Vomiting—Estropipate—osteoporosis	0.000999	0.00121	CcSEcCtD
Carboprost Tromethamine—Dizziness—Ibandronate—osteoporosis	0.000997	0.0012	CcSEcCtD
Carboprost Tromethamine—Rash—Estropipate—osteoporosis	0.000991	0.0012	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Estropipate—osteoporosis	0.00099	0.0012	CcSEcCtD
Carboprost Tromethamine—Nervousness—Estradiol—osteoporosis	0.000989	0.0012	CcSEcCtD
Carboprost Tromethamine—Back pain—Estradiol—osteoporosis	0.000985	0.00119	CcSEcCtD
Carboprost Tromethamine—Headache—Estropipate—osteoporosis	0.000985	0.00119	CcSEcCtD
Carboprost Tromethamine—Vomiting—Alendronate—osteoporosis	0.000984	0.00119	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000983	0.00119	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Risedronate—osteoporosis	0.000982	0.00119	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Estradiol—osteoporosis	0.000979	0.00118	CcSEcCtD
Carboprost Tromethamine—Rash—Alendronate—osteoporosis	0.000976	0.00118	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Alendronate—osteoporosis	0.000975	0.00118	CcSEcCtD
Carboprost Tromethamine—Headache—Alendronate—osteoporosis	0.00097	0.00117	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Zoledronate—osteoporosis	0.000969	0.00117	CcSEcCtD
Carboprost Tromethamine—Vomiting—Raloxifene—osteoporosis	0.000968	0.00117	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MGLL—osteoporosis	0.000966	0.00627	CbGpPWpGaD
Carboprost Tromethamine—Dyspnoea—Zoledronate—osteoporosis	0.000962	0.00116	CcSEcCtD
Carboprost Tromethamine—Rash—Raloxifene—osteoporosis	0.00096	0.00116	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Raloxifene—osteoporosis	0.000959	0.00116	CcSEcCtD
Carboprost Tromethamine—Somnolence—Zoledronate—osteoporosis	0.000959	0.00116	CcSEcCtD
Carboprost Tromethamine—Vomiting—Ibandronate—osteoporosis	0.000958	0.00116	CcSEcCtD
Carboprost Tromethamine—Headache—Raloxifene—osteoporosis	0.000954	0.00115	CcSEcCtD
Carboprost Tromethamine—Rash—Ibandronate—osteoporosis	0.00095	0.00115	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Ibandronate—osteoporosis	0.00095	0.00115	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000946	0.00114	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MGLL—osteoporosis	0.000946	0.00614	CbGpPWpGaD
Carboprost Tromethamine—Headache—Ibandronate—osteoporosis	0.000944	0.00114	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000939	0.00113	CcSEcCtD
Carboprost Tromethamine—Vomiting—Calcitriol—osteoporosis	0.000938	0.00113	CcSEcCtD
Carboprost Tromethamine—Nausea—Estropipate—osteoporosis	0.000934	0.00113	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Pamidronate—osteoporosis	0.000934	0.00113	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000933	0.00113	CcSEcCtD
Carboprost Tromethamine—Angioedema—Estradiol—osteoporosis	0.000931	0.00112	CcSEcCtD
Carboprost Tromethamine—Rash—Calcitriol—osteoporosis	0.00093	0.00112	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Calcitriol—osteoporosis	0.00093	0.00112	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000926	0.00112	CcSEcCtD
Carboprost Tromethamine—Headache—Calcitriol—osteoporosis	0.000924	0.00112	CcSEcCtD
Carboprost Tromethamine—Somnolence—Conjugated Estrogens—osteoporosis	0.000923	0.00112	CcSEcCtD
Carboprost Tromethamine—Pain—Zoledronate—osteoporosis	0.000922	0.00111	CcSEcCtD
Carboprost Tromethamine—Nausea—Alendronate—osteoporosis	0.00092	0.00111	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Risedronate—osteoporosis	0.000915	0.00111	CcSEcCtD
Carboprost Tromethamine—Vertigo—Estradiol—osteoporosis	0.000915	0.00111	CcSEcCtD
Carboprost Tromethamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000914	0.0011	CcSEcCtD
Carboprost Tromethamine—Syncope—Estradiol—osteoporosis	0.000913	0.0011	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CALCA—osteoporosis	0.000908	0.0059	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Raloxifene—osteoporosis	0.000904	0.00109	CcSEcCtD
Carboprost Tromethamine—Palpitations—Estradiol—osteoporosis	0.0009	0.00109	CcSEcCtD
Carboprost Tromethamine—Nausea—Ibandronate—osteoporosis	0.000895	0.00108	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Estradiol—osteoporosis	0.000895	0.00108	CcSEcCtD
Carboprost Tromethamine—Asthenia—Risedronate—osteoporosis	0.000891	0.00108	CcSEcCtD
Carboprost Tromethamine—Cough—Estradiol—osteoporosis	0.000889	0.00107	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CALCA—osteoporosis	0.000889	0.00577	CbGpPWpGaD
Carboprost Tromethamine—Pain—Conjugated Estrogens—osteoporosis	0.000888	0.00107	CcSEcCtD
Carboprost Tromethamine—Hypertension—Estradiol—osteoporosis	0.000879	0.00106	CcSEcCtD
Carboprost Tromethamine—Nausea—Calcitriol—osteoporosis	0.000877	0.00106	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000872	0.00105	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Pamidronate—osteoporosis	0.00087	0.00105	CcSEcCtD
Carboprost Tromethamine—Myalgia—Estradiol—osteoporosis	0.000867	0.00105	CcSEcCtD
Carboprost Tromethamine—Chest pain—Estradiol—osteoporosis	0.000867	0.00105	CcSEcCtD
Carboprost Tromethamine—Anxiety—Estradiol—osteoporosis	0.000864	0.00104	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Zoledronate—osteoporosis	0.000853	0.00103	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Risedronate—osteoporosis	0.00085	0.00103	CcSEcCtD
Carboprost Tromethamine—Asthenia—Pamidronate—osteoporosis	0.000847	0.00102	CcSEcCtD
Carboprost Tromethamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000843	0.00102	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Estradiol—osteoporosis	0.000831	0.001	CcSEcCtD
Carboprost Tromethamine—Infection—Estradiol—osteoporosis	0.000826	0.000998	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000822	0.00534	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Risedronate—osteoporosis	0.000821	0.000993	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000821	0.000992	CcSEcCtD
Carboprost Tromethamine—Shock—Estradiol—osteoporosis	0.000818	0.000988	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Estradiol—osteoporosis	0.000811	0.00098	CcSEcCtD
Carboprost Tromethamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00081	0.000979	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Pamidronate—osteoporosis	0.000808	0.000976	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000804	0.00522	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Estradiol—osteoporosis	0.000804	0.000971	CcSEcCtD
Carboprost Tromethamine—Rash—Ethinyl Estradiol—osteoporosis	0.000803	0.000971	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000803	0.00097	CcSEcCtD
Carboprost Tromethamine—Headache—Ethinyl Estradiol—osteoporosis	0.000798	0.000965	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Zoledronate—osteoporosis	0.000795	0.00096	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SOST—osteoporosis	0.000794	0.00516	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Risedronate—osteoporosis	0.00079	0.000955	CcSEcCtD
Carboprost Tromethamine—Rash—Risedronate—osteoporosis	0.000783	0.000947	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Risedronate—osteoporosis	0.000783	0.000946	CcSEcCtD
Carboprost Tromethamine—Dizziness—Pamidronate—osteoporosis	0.000781	0.000944	CcSEcCtD
Carboprost Tromethamine—Headache—Risedronate—osteoporosis	0.000778	0.00094	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SOST—osteoporosis	0.000777	0.00505	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Zoledronate—osteoporosis	0.000774	0.000935	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000765	0.000925	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000757	0.000915	CcSEcCtD
Carboprost Tromethamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000757	0.000915	CcSEcCtD
Carboprost Tromethamine—Vomiting—Pamidronate—osteoporosis	0.000751	0.000907	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Estradiol—osteoporosis	0.000746	0.000902	CcSEcCtD
Carboprost Tromethamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000745	0.000901	CcSEcCtD
Carboprost Tromethamine—Rash—Pamidronate—osteoporosis	0.000745	0.0009	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Pamidronate—osteoporosis	0.000744	0.000899	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Estradiol—osteoporosis	0.000741	0.000896	CcSEcCtD
Carboprost Tromethamine—Headache—Pamidronate—osteoporosis	0.00074	0.000894	CcSEcCtD
Carboprost Tromethamine—Somnolence—Estradiol—osteoporosis	0.000739	0.000893	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Zoledronate—osteoporosis	0.000738	0.000892	CcSEcCtD
Carboprost Tromethamine—Nausea—Risedronate—osteoporosis	0.000738	0.000892	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CALCR—osteoporosis	0.000718	0.00466	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTH1R—osteoporosis	0.000718	0.00466	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Zoledronate—osteoporosis	0.000713	0.000862	CcSEcCtD
Carboprost Tromethamine—Pain—Estradiol—osteoporosis	0.000711	0.000859	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000711	0.000859	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTH—osteoporosis	0.000703	0.00457	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CALCR—osteoporosis	0.000703	0.00457	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTH1R—osteoporosis	0.000703	0.00457	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Pamidronate—osteoporosis	0.000701	0.000848	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTH—osteoporosis	0.000689	0.00447	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000687	0.00083	CcSEcCtD
Carboprost Tromethamine—Vomiting—Zoledronate—osteoporosis	0.000686	0.000829	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR2—osteoporosis	0.000685	0.00445	CbGpPWpGaD
Carboprost Tromethamine—Rash—Zoledronate—osteoporosis	0.00068	0.000822	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Zoledronate—osteoporosis	0.00068	0.000821	CcSEcCtD
Carboprost Tromethamine—Headache—Zoledronate—osteoporosis	0.000676	0.000817	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR2—osteoporosis	0.000671	0.00436	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Conjugated Estrogens—osteoporosis	0.00066	0.000798	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Estradiol—osteoporosis	0.000657	0.000794	CcSEcCtD
Carboprost Tromethamine—Rash—Conjugated Estrogens—osteoporosis	0.000655	0.000791	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000654	0.000791	CcSEcCtD
Carboprost Tromethamine—Headache—Conjugated Estrogens—osteoporosis	0.000651	0.000786	CcSEcCtD
Carboprost Tromethamine—Nausea—Zoledronate—osteoporosis	0.000641	0.000774	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTH—osteoporosis	0.000639	0.00415	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTH—osteoporosis	0.000625	0.00406	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000624	0.00405	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR2—osteoporosis	0.000622	0.00404	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Conjugated Estrogens—osteoporosis	0.000617	0.000746	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Estradiol—osteoporosis	0.000612	0.00074	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000611	0.00396	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR2—osteoporosis	0.000609	0.00396	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Estradiol—osteoporosis	0.000596	0.000721	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—WNT1—osteoporosis	0.000585	0.0038	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTHLH—osteoporosis	0.000583	0.00378	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—WNT1—osteoporosis	0.000573	0.00372	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MGLL—osteoporosis	0.000571	0.0037	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTHLH—osteoporosis	0.000571	0.0037	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Estradiol—osteoporosis	0.000569	0.000687	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MGLL—osteoporosis	0.000559	0.00363	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LRP5—osteoporosis	0.000557	0.00362	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Estradiol—osteoporosis	0.00055	0.000664	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LRP5—osteoporosis	0.000545	0.00354	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LRP6—osteoporosis	0.000533	0.00346	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTHLH—osteoporosis	0.000529	0.00344	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Estradiol—osteoporosis	0.000529	0.000639	CcSEcCtD
Carboprost Tromethamine—Rash—Estradiol—osteoporosis	0.000524	0.000633	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Estradiol—osteoporosis	0.000524	0.000633	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LRP6—osteoporosis	0.000521	0.00339	CbGpPWpGaD
Carboprost Tromethamine—Headache—Estradiol—osteoporosis	0.000521	0.000629	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTHLH—osteoporosis	0.000518	0.00336	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CALCA—osteoporosis	0.000513	0.00333	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CALCA—osteoporosis	0.000502	0.00326	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Estradiol—osteoporosis	0.000494	0.000597	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—osteoporosis	0.000475	0.00308	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CALCA—osteoporosis	0.000466	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—osteoporosis	0.000465	0.00302	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CALCA—osteoporosis	0.000456	0.00296	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TLN1—osteoporosis	0.00045	0.00292	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TLN1—osteoporosis	0.00044	0.00286	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—P4HB—osteoporosis	0.000388	0.00252	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—P4HB—osteoporosis	0.00038	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTH—osteoporosis	0.000377	0.00245	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAP1A—osteoporosis	0.000371	0.00241	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTH—osteoporosis	0.000369	0.0024	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR2—osteoporosis	0.000368	0.00239	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000366	0.00238	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADCY5—osteoporosis	0.000365	0.00237	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAP1A—osteoporosis	0.000363	0.00236	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NFATC1—osteoporosis	0.000362	0.00235	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR2—osteoporosis	0.00036	0.00234	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DKK1—osteoporosis	0.000359	0.00233	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000358	0.00233	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADCY5—osteoporosis	0.000357	0.00232	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NFATC1—osteoporosis	0.000354	0.0023	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DKK1—osteoporosis	0.000351	0.00228	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—WNT1—osteoporosis	0.000346	0.00224	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—WNT1—osteoporosis	0.000338	0.0022	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGA—osteoporosis	0.000336	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADCY5—osteoporosis	0.000331	0.00215	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGA—osteoporosis	0.000329	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADCY5—osteoporosis	0.000324	0.00211	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BMP2—osteoporosis	0.000313	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTHLH—osteoporosis	0.000313	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTHLH—osteoporosis	0.000306	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BMP2—osteoporosis	0.000306	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGB—osteoporosis	0.000306	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGB—osteoporosis	0.0003	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSMA2—osteoporosis	0.000295	0.00192	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSMA5—osteoporosis	0.000295	0.00192	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSMA2—osteoporosis	0.000289	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSMA5—osteoporosis	0.000289	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CALCA—osteoporosis	0.000275	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CALCA—osteoporosis	0.000269	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—osteoporosis	0.000268	0.00174	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—osteoporosis	0.000263	0.00171	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KL—osteoporosis	0.00025	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KL—osteoporosis	0.000245	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—osteoporosis	0.000244	0.00158	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—osteoporosis	0.000239	0.00155	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6R—osteoporosis	0.000238	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6R—osteoporosis	0.000233	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADCY5—osteoporosis	0.000196	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADCY5—osteoporosis	0.000192	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—osteoporosis	0.000189	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—osteoporosis	0.000185	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IRS2—osteoporosis	0.000171	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IRS2—osteoporosis	0.000168	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LEP—osteoporosis	0.000168	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LEP—osteoporosis	0.000164	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ESR1—osteoporosis	0.00016	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ESR1—osteoporosis	0.000157	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IRS1—osteoporosis	0.00015	0.000971	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IRS1—osteoporosis	0.000146	0.00095	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—osteoporosis	0.000144	0.000935	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—osteoporosis	0.000141	0.000915	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6R—osteoporosis	0.00014	0.000912	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1—osteoporosis	0.000139	0.000899	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6R—osteoporosis	0.000138	0.000893	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1—osteoporosis	0.000136	0.00088	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—osteoporosis	0.000106	0.000688	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—osteoporosis	0.000104	0.000673	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—osteoporosis	8.33e-05	0.000541	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—osteoporosis	8.31e-05	0.000539	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—osteoporosis	8.15e-05	0.000529	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—osteoporosis	8.13e-05	0.000528	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—osteoporosis	6.26e-05	0.000406	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—osteoporosis	6.13e-05	0.000398	CbGpPWpGaD
